Empirical Asset Management, LLC Blueprint Medicines Corp Transaction History
Empirical Asset Management, LLC
- $3.46 Billion
- Q4 2024
A detailed history of Empirical Asset Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Empirical Asset Management, LLC holds 26,921 shares of BPMC stock, worth $3.01 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
26,921Holding current value
$3.01 Million% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
350Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$748 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$744 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$603 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$444 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$310 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.69B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...